Reliv International Expands Scientific Advisory Board With Internationally Recognized Pharmacologist and Nutraceutical Expert

CHESTERFIELD, Mo., Jan 30, 2007 /PRNewswire-FirstCall via COMTEX/ -- Reliv International, Inc. (RELV) , a developer, manufacturer and marketer of a proprietary line of nutritional supplements, has expanded its Scientific Advisory Board with the addition of two new members with sterling international reputations: pharmacologist James Jamieson of St. Louis and nutraceutical expert Dr. Clare M. Hasler of Davis, Calif.

"These two scientists bring tremendous experience to Reliv. Their expertise complements the expertise of our other Scientific Advisory Board members, both of whom are physicians," said Reliv Vice President Dr. Carl W. Hastings, who heads the company's research and development. "The Reliv Scientific Advisory Board reviews potential new ingredients, evaluates new products and provides recommendations to support Reliv's research," Hastings said.

James Jamieson is a world-renowned pharmacologist who has consulted for Merck & Co., 3M, GlaxoSmithKline, Armour Pharmaceutical, Hoffmann-LaRoche, Warner Lambert and Dow Chemical. He has developed more that 100 pharmaceutical products and is recognized as an expert in drug delivery systems.

Jamieson created the first acetaminophen tablet; the first non-alcohol based children's cough and cold formula, Triaminic; the first topical vitamin C; Sinex Nasal Spray; and he worked on the development of the nitroglycerine patch.
For years Jamieson has been an authority figure on the subject of anti- aging, and he co-authored the book, Growth Hormone: The Methuselah Factor, which has sold more than 1.5 million copies. His company supplies Reliv with symbiotropin, one of the active ingredients in the ReversAge product.

Jamieson is actually a third generation scientist. His grandfather manufactured the first oral penicillin and the first liquid antacid. His parents owned pharmacies in St. Louis. And Jamieson, himself, founded three pharmacy chains and the first mail-order pharmacy in the United States.

He was educated at Washington University in St. Louis and is a graduate of the Brooklyn College of Pharmacy. He and his wife live in the St. Louis area.

Dr. Clare Hasler is an internationally recognized expert in the areas of functional foods and nutraceuticals. She is founding executive director of the Robert Mondavi Institute for Wine and Food Science at the University of California, Davis, and she is a distinguished lecturer for the Institute of Food Technologists. She serves on the editorial boards of the Journal of Nutraceuticals, Functional Foods and Medical Foods and the Journal of the American Nutraceutical Association, among other editorial positions.

Hasler was the founding director of the Functional Foods for Health Program, a joint effort between the University of Illinois at Chicago and University of Illinois at Urbana-Champaign. She has written extensively on functional foods and other health-related issues. Dr. Hasler earned a dual Ph.D. in Human Nutrition and Environmental Toxicology from Michigan State University.

Jamieson and Hasler join Dr. Linda Bivins of Chattanooga, Tenn., and Dr. Stephen Pfeiffer of Indianapolis, both board certified family physicians, on the Reliv Scientific Advisory Board.

About Reliv
Reliv International, Inc., based in suburban St. Louis, Mo., develops, manufactures and markets a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. Reliv sells its products through an international network marketing system of approximately 65,000 independent distributors. Reliv International's common stock trades on NASDAQ under the symbol RELV. Additional information about Reliv International, Inc. can be obtained on the Web at

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.